Literature DB >> 31315435

Weibel-Palade Bodies Orchestrate Pericytes During Angiogenesis.

Mélissande Cossutta1, Marie Darche1, Gilles Carpentier1, Claire Houppe1, Matteo Ponzo1,2, Fabio Raineri1, Benoit Vallée1, Maud-Emmanuelle Gilles1, Delphine Villain1, Emilie Picard3, Caterina Casari4, Cécile Denis4, Michel Paques5, José Courty1, Ilaria Cascone1.   

Abstract

Objective Weibel-Palade bodies (WPBs) are endothelial cell (EC)-specific organelles formed by vWF (von Willebrand factor) polymerization and that contain the proangiogenic factor Ang-2 (angiopoietin-2). WPB exocytosis has been shown to be implicated for vascular repair and inflammatory responses. Here, we investigate the role of WPBs during angiogenesis and vessel stabilization. Approach and Results WPB density in ECs decreased at the angiogenic front of retinal vascular network during development and neovascularization compared with stable vessels. In vitro, VEGF (vascular endothelial growth factor) induced a VEGFR-2 (vascular endothelial growth factor receptor-2)-dependent exocytosis of WPBs that contain Ang-2 and consequently the secretion of vWF and Ang-2. Blocking VEGF-dependant WPB exocytosis and Ang-2 secretion promoted pericyte migration toward ECs. Pericyte migration was inhibited by adding recombinant Ang-2 or by silencing Ang-1 (angiopoietin-1) or Tie2 (angiopoietin-1 receptor) in pericytes. Consistently, in vivo anti-VEGF treatment induced accumulation of WPBs in retinal vessels because of the inhibition of WPB exocytosis and promoted the increase of pericyte coverage of retinal vessels during angiogenesis. In tumor angiogenesis, depletion of WPBs in vWF knockout tumor-bearing mice promoted an increase of tumor angiogenesis and a decrease of pericyte coverage of tumor vessels. By another approach, normalized tumor vessels had higher WPB density. Conclusions We demonstrate that WPB exocytosis and Ang-2 secretion are regulated during angiogenesis to limit pericyte coverage of remodeling vessels by disrupting Ang-1/Tie2 autocrine signaling in pericytes.

Entities:  

Keywords:  angiogenesis; angiopoietin-2; endothelial cells; pericytes; tumor vessel normalization; vascular endothelial growth factor; von Willebrand factor

Mesh:

Substances:

Year:  2019        PMID: 31315435     DOI: 10.1161/ATVBAHA.119.313021

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  5 in total

1.  Ensembles of endothelial and mural cells promote angiogenesis in prenatal human brain.

Authors:  Elizabeth E Crouch; Aparna Bhaduri; Madeline G Andrews; Arantxa Cebrian-Silla; Loukas N Diafos; Janeth Ochoa Birrueta; Kaylee Wedderburn-Pugh; Edward J Valenzuela; Neal K Bennett; Ugomma C Eze; Carmen Sandoval-Espinosa; Jiapei Chen; Cristina Mora; Jayden M Ross; Clare E Howard; Susana Gonzalez-Granero; Jaime Ferrer Lozano; Maximo Vento; Maximilian Haeussler; Mercedes F Paredes; Ken Nakamura; Jose Manuel Garcia-Verdugo; Arturo Alvarez-Buylla; Arnold R Kriegstein; Eric J Huang
Journal:  Cell       Date:  2022-09-29       Impact factor: 66.850

Review 2.  Proteomics and its applications in breast cancer.

Authors:  Anca-Narcisa Neagu; Danielle Whitham; Emma Buonanno; Avalon Jenkins; Teodora Alexa-Stratulat; Bogdan Ionel Tamba; Costel C Darie
Journal:  Am J Cancer Res       Date:  2021-09-15       Impact factor: 5.942

Review 3.  Role of von Willebrand factor in the angiogenesis of lung adenocarcinoma.

Authors:  Xin Li; Zhong Lu
Journal:  Oncol Lett       Date:  2022-05-05       Impact factor: 3.111

4.  MicroRNA‑21 contributes to renal cell carcinoma cell invasiveness and angiogenesis via the PDCD4/c‑Jun (AP‑1) signalling pathway.

Authors:  Bo Fan; Yiying Jin; Hongshuo Zhang; Rui Zhao; Man Sun; Mengfan Sun; Xiaoying Yuan; Wei Wang; Xiaogang Wang; Zhiqi Chen; Wankai Liu; Na Yu; Qun Wang; Tingjiao Liu; Xiancheng Li
Journal:  Int J Oncol       Date:  2019-12-02       Impact factor: 5.650

5.  Quantifying Vascular Density in Tissue Engineered Constructs Using Machine Learning.

Authors:  Hannah A Strobel; Alex Schultz; Sarah M Moss; Rob Eli; James B Hoying
Journal:  Front Physiol       Date:  2021-04-27       Impact factor: 4.566

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.